Global Metabolism Assays Market Report 2023-2028 - Increased Prevalence of Obesity and Diabetes to Drive Industry Growth

Dublin, Nov. 15, 2023 (GLOBE NEWSWIRE) -- The "Global Metabolism Assays Market by Product (Instruments, Assays Kits), Technology (Colorimetry, Fluorimetry, Spectrometry), Application (Diagnostics (Diabetes, Obesity), Research), End User (Hospitals, Diagnostic Laboratories), & Region - Forecast to 2028" report has been added to's offering.

The metabolism assays market is projected to reach USD 2.1 billion by 2028 from USD 1.4 billion in 2023, at a CAGR of 7.8%

This research report categorizes the Metabolism Assays Market by product, technology, application, end-user, and region. The report's scope encompasses comprehensive information on the major factors, including drivers, restraints, challenges, and opportunities, that exert an influence on the growth of the Metabolism Assays Market.

The market's growth is primarily propelled by government support and funding for metabolic research, the increasing utilization of metabolism assays in the fitness and sports industry, and the rising awareness of the importance of early diagnosis. Nevertheless, concerns related to the high cost of metabolism assays act as a hindrance to market growth.

North America is expected to hold a significant market share due to the presence of robust pharmaceutical and biotechnology industries engaged in drug discovery, toxicity testing, and development. Moreover, the region benefits from a growing population afflicted with target diseases, further supporting the expansion of the metabolism assays market. Conversely, Asia Pacific is projected to register the highest Compound Annual Growth Rate (CAGR) during the forecast period.

A thorough analysis of key industry players is conducted to provide insights into their business profiles, solutions, services, key strategies, contracts, partnerships, and agreements. Additionally, the report covers aspects such as new product and service launches, mergers and acquisitions, and recent developments within the metabolism assays market. Competitive analysis of emerging startups within the metabolism assays market ecosystem is also included.

Furthermore, the report offers an in-depth evaluation of market ranking, growth strategies, and service offerings of prominent players, including Merck KGaA (Germany), Thermo Fisher (US), Abcam Plc. (UK), and Agilent Technologies Inc. (US), among others, in the metabolism assays market.

The assay kits & reagents segment accounted for the highest market share in the metabolism assays market, by product, during the forecast period

Based on the product segment, the metabolism assays market is classified into instruments & analyzers and assay kits & reagents. In 2022, the assay kits & reagents segment dominated the products market.

This segment is also estimated to grow at the highest CAGR during the forecast period. The large share is due to their integration with technologies, such as wearable devices and wide use in diagnostics as it is the major application.

Pharmaceutical & Biotechnology Companies and CROs & Academic Research Institutes accounted for the highest CAGR during the forecast period

Based on end users, the metabolism assays market is segmented into hospitals, diagnostic laboratories, and pharmaceutical & biotechnology companies and CROs & academic research institutes. The pharmaceutical & biotechnology companies and CROs & academic research institutes segment dominated the metabolism assays market in 2022.

The diagnostic laboratories segment is expected to grow at the highest CAGR during the forecast period. The large share of this segment can be attributed to increasing R&D investments by pharmaceutical & biotechnology companies on metabolic research.

Key Attributes:

Report AttributeDetails
No. of Pages188
Forecast Period2023 - 2028
Estimated Market Value (USD) in 2023$1.4 Billion
Forecasted Market Value (USD) by 2028$2.1 Billion
Compound Annual Growth Rate7.8%
Regions CoveredGlobal

Premium Insights

  • Increased Prevalence of Obesity and Diabetes to Drive Metabolism Assays Industry
  • Assay Kits & Reagents Accounted for Largest Share in 2022
  • Germany to Register Highest Growth Rate During Forecast Period
  • Asia-Pacific Market to Witness Fastest Growth During Forecast Period
  • Developing Economies to Register Higher Growth During Forecast Period

Market Dynamics


  • Increasing Funding and Investments in Metabolic Research
  • Drug Discovery and Development
  • Rise in Prevalence of Chronic Diseases
  • Increased Use of Metabolism Assays in Fitness and Sports
  • Growing Demand for Personalized Medicines


  • High Cost of Metabolism Assay Analyzers
  • Presence of Alternative Methods and Techniques


  • Integration with Wearable Devices
  • Growing Life Science Research in Emerging Economies


  • Complexity of Assay Development

Company Profiles

Key Players

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Abcam plc.
  • Agilent Technologies Inc.
  • Kaneka Eurogentec S.A.
  • Sartorius Ag
  • Promega Corporation
  • Elabscience Biotechnology Inc.
  • Raybiotech Life, Inc.
  • Bmg Labtech
  • Biotrend Chemikalien GmbH

Other Players

  • 3H Biomedical Ab
  • Bioassay Systems
  • Emelca Bioscience
  • Creative Bioarray
  • Tempo Bioscience, Inc.
  • Ncardia
  • Novocib
  • Eton Bioscience, Inc.
  • Cayman Chemical Company
  • Enzo Life Sciences, Inc.
  • Abnova Corporation

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Global Metabolism Assays Market

Contact Data